1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Changing lifestyle and dietary patterns resulting in damage of liver
5.2.2. Increasing incidence of obesity and overweight among people
5.2.3. Favorable reimbursement policies for treatment of liver fibrosis
5.3. Restraints
5.3.1. Reduced rate of voluntary screening of disease
5.4. Opportunities
5.4.1. Emerging research funding from private organization toward R&D activities
5.4.2. Increasing expenditure on development of healthcare services
5.5. Challenges
5.5.1. Dearth of awareness of the disease and the available treatment

6. Liver Fibrosis Drugs Market, by Drug Class
6.1. Introduction
6.2. Interferon Therapy
6.3. Maloti Lipid
6.4. Nucleoside Analog

7. Liver Fibrosis Drugs Market, by Distribution
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies

8. Americas Liver Fibrosis Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Liver Fibrosis Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Liver Fibrosis Drugs Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Arbutus Biopharma
12.2. AstraZeneca
12.3. Bayer AG
12.4. Biogen Idec
12.5. Bristol-Myers Squibb Company
12.6. Celgene Corporation,
12.7. Dicerna Pharmaceuticals, Inc.
12.8. Dynavax Technologies Corporation
12.9. FibroGen, Inc.
12.10. Gilead Sciences, Inc.
12.11. GlaxoSmithKline plc
12.12. Hepion Pharmaceutical
12.13. Johnson and Johnson
12.14. LG Life Science Ltd.
12.15. Madrigal Pharmaceuticals
12.16. Merck & Co., Inc.
12.17. Mirum Pharmaceuticals
12.18. Moderna Therapeutics
12.19. Novartis AG
12.20. Pfizer Inc.
12.21. Pharmaxis Limited
12.22. Roche
12.23. Sanofi
12.24. Translate Bio
12.25. Tri-Prime

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL LIVER FIBROSIS DRUGS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
FIGURE 5. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2026
FIGURE 7. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY INTERFERON THERAPY, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY INTERFERON THERAPY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY MALOTI LIPID, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY MALOTI LIPID, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY NUCLEOSIDE ANALOG, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY NUCLEOSIDE ANALOG, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
FIGURE 14. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD BILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DISTRIBUTION, 2026
FIGURE 16. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. AMERICAS LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 23. ARGENTINA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 24. BRAZIL LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 25. CANADA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 26. MEXICO LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 27. UNITED STATES LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 28. ASIA-PACIFIC LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 29. AUSTRALIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 30. CHINA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 31. INDIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 32. INDONESIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 33. JAPAN LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 34. MALAYSIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 35. PHILIPPINES LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 36. SINGAPORE LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. SOUTH KOREA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. TAIWAN LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. THAILAND LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. FRANCE LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. GERMANY LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. ITALY LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. NETHERLANDS LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. QATAR LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. RUSSIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. SAUDI ARABIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. SOUTH AFRICA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. SPAIN LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. UNITED ARAB EMIRATES LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. UNITED KINGDOM LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. GLOBAL LIVER FIBROSIS DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL LIVER FIBROSIS DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL LIVER FIBROSIS DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL LIVER FIBROSIS DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY INTERFERON THERAPY, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY MALOTI LIPID, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY NUCLEOSIDE ANALOG, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL LIVER FIBROSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. AMERICAS LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 13. ARGENTINA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 14. BRAZIL LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 15. CANADA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 16. MEXICO LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 17. UNITED STATES LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. ASIA-PACIFIC LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. AUSTRALIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. CHINA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. INDIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. INDONESIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. JAPAN LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. MALAYSIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. PHILIPPINES LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. SINGAPORE LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. SOUTH KOREA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. TAIWAN LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. THAILAND LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. FRANCE LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. GERMANY LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. ITALY LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. NETHERLANDS LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. QATAR LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. RUSSIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. SAUDI ARABIA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. SOUTH AFRICA LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. SPAIN LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. UNITED ARAB EMIRATES LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. UNITED KINGDOM LIVER FIBROSIS DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. GLOBAL LIVER FIBROSIS DRUGS MARKET: SCORES
TABLE 43. GLOBAL LIVER FIBROSIS DRUGS MARKET: BUSINESS STRATEGY
TABLE 44. GLOBAL LIVER FIBROSIS DRUGS MARKET: PRODUCT SATISFACTION
TABLE 45. GLOBAL LIVER FIBROSIS DRUGS MARKET: RANKING
TABLE 46. GLOBAL LIVER FIBROSIS DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 47. GLOBAL LIVER FIBROSIS DRUGS MARKET: MERGER & ACQUISITION
TABLE 48. GLOBAL LIVER FIBROSIS DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 49. GLOBAL LIVER FIBROSIS DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 50. GLOBAL LIVER FIBROSIS DRUGS MARKET: INVESTMENT & FUNDING
TABLE 51. GLOBAL LIVER FIBROSIS DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 52. GLOBAL LIVER FIBROSIS DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Arbutus Biopharma
AstraZeneca
Bayer AG
Biogen Idec
Bristol-Myers Squibb Company
Celgene Corporation,
Dicerna Pharmaceuticals, Inc.
Dynavax Technologies Corporation
FibroGen, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Hepion Pharmaceutical
Johnson and Johnson
LG Life Science Ltd.
Madrigal Pharmaceuticals
Merck & Co., Inc.
Mirum Pharmaceuticals
Moderna Therapeutics
Novartis AG
Pfizer Inc.
Pharmaxis Limited
Roche
Sanofi
Translate Bio
Tri-Prime